STAGE IV OVARIAN CANCER AJCC V8

This early-stage study tests a procedure called PIPAC that turns liquid chemotherapy into a fine mist and sprays it directly into the abdomen during a minimally invasive surgery. It is for people with ovarian, uterine, appendix, colorectal, or stomach cancer that has spread to th…

This early-phase study tests a wearable device that creates electric fields (tumor treating fields) combined with either cabozantinib or a chemo-immunotherapy pair (nab-paclitaxel and atezolizumab) in people with advanced solid tumors in the abdomen or chest. The goal is to see i…

This study tests a drug called PLX038 in people with ovarian, fallopian tube, or peritoneal cancer that has spread and no longer responds to platinum chemotherapy. The goal is to see if PLX038 can shrink tumors by blocking enzymes that cancer cells need to grow. About 43 adults w…

This early-phase study tests a new drug called IACS-6274, alone or with other medicines, in people with advanced solid tumors (like melanoma, ovarian, or head and neck cancers) that have not responded to standard treatments. The main goal is to find the safest dose and understand…

This study tests whether taking probiotics (friendly bacteria) can improve gut and vaginal health in 161 women with advanced or recurrent ovarian cancer who are receiving platinum chemotherapy. Researchers will compare changes in the microbiome, quality of life, and symptoms betw…

This study is testing a new way to find ovarian cancer earlier by looking at DNA from a uterine wash and proteins in the blood. Researchers will collect samples from 250 women before surgery for a suspected ovarian mass. The goal is to see if these tests can tell the difference b…

This study tests whether a personalized, automated exercise program using a Fitbit can help people with advanced ovarian or endometrial cancer become more active. Researchers want to see if reaching 150 minutes of moderate exercise per week improves quality of life, physical func…